NEI
CLVS

Northwest & Ethical Investments’s Clovis Oncology, Inc. CLVS Stock Holding History

Northwest & Ethical Investments’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-900
Closed -$26.4K – 411
2018
Q3 		$26.4K Sell
900
-700
-44% -$27.1K ﹤0.01% 363
2018
Q2 		$72.8K Buy
1,600
+200
+14% +$9.73K ﹤0.01% 354
2018
Q1 		$73.9K Buy
+1,400
New +$81.7K 0.01% 350

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Northwest & Ethical Investments's CLVS Position: Q4 2018 in Review

Northwest & Ethical Investments sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 900 shares — an estimated $26.4K sold.

Northwest & Ethical Investments first reported a position in CLVS in Q1 2018 and held it in 3 quarters. The position peaked at $73.9K in Q1 2018. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • Northwest & Ethical Investments reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • Northwest & Ethical Investments sold 900 Clovis Oncology, Inc. shares in Q4 2018, an estimated $26.4K.
  • Northwest & Ethical Investments first reported a position in Clovis Oncology, Inc. in Q1 2018 and held it in 3 quarters.
  • Northwest & Ethical Investments's Clovis Oncology, Inc. position peaked at $73.9K in Q1 2018.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Northwest & Ethical Investments's 13F filing for Q4 2018, filed 8 Jul 2025.